Analysis on Short-Term Outcomes for Cerebral Protection Treatment in Post Severe Traumatic Brain Injury Patients: A Single Neurosurgical Centre Study.

IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Malaysian Journal of Medical Sciences Pub Date : 2024-04-01 Epub Date: 2024-04-23 DOI:10.21315/mjms2024.31.2.12
Ahmad Fikri Muhammad Mustafa, Laila Ab Mukmin, Mohd Zulfakar Mazlan, Abdul Rahman Izaini Ghani, Wan Mohd Nazaruddin Wan Hassan, Mohamad Hasyizan Hassan
{"title":"Analysis on Short-Term Outcomes for Cerebral Protection Treatment in Post Severe Traumatic Brain Injury Patients: A Single Neurosurgical Centre Study.","authors":"Ahmad Fikri Muhammad Mustafa, Laila Ab Mukmin, Mohd Zulfakar Mazlan, Abdul Rahman Izaini Ghani, Wan Mohd Nazaruddin Wan Hassan, Mohamad Hasyizan Hassan","doi":"10.21315/mjms2024.31.2.12","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Severe traumatic brain injury (TBI) is a leading cause of disability worldwide and cerebral protection (CP) management might determine the outcome of the patient. CP in severe TBI is to protect the brain from further insults, optimise cerebral metabolism and prevent secondary brain injury. This study aimed to analyse the short-term Glasgow Outcome Scale (GOS) at the intensive care unit (ICU) discharge and a month after ICU discharge of patients post CP and factors associated with the favourable outcome.</p><p><strong>Methods: </strong>This is a prospective cohort study from January 2021 to January 2022. The short-term outcomes of patients were evaluated upon ICU discharge and 1 month after ICU discharge using GOS. Favourable outcome was defined as GOS 4 and 5. Generalised Estimation Equation (GEE) was adopted to conduct bivariate GEE and subsequently multivariate GEE to evaluate the factors associated with favourable outcome at ICU discharge and 1 month after discharge.</p><p><strong>Results: </strong>A total of 92 patients with severe TBI with GOS of 8 and below admitted to ICU received CP management. Proportion of death is 17% at ICU discharge and 0% after 1 month of ICU discharge. Proportion of favourable outcome is 26.1% at ICU discharge and 61.1% after 1 month of ICU discharge. Among factors evaluated, age (odds ratio [OR] = 0.96; 95% CI: 0.94, 0.99; <i>P</i> = 0.004), duration of CP (OR = 0.41; 95% CI: 0.20, 0.84; <i>P</i> = 0.014) and hyperosmolar therapy (OR = 0.41; CI 95%: 0.21, 0.83; <i>P</i> = 0.013) had significant association.</p><p><strong>Conclusion: </strong>CP in younger age, longer duration of CP and patient not receiving hyperosmolar therapy are associated with favourable outcomes. We recommend further clinical trial to assess long term outcome of CP.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057832/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21315/mjms2024.31.2.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Severe traumatic brain injury (TBI) is a leading cause of disability worldwide and cerebral protection (CP) management might determine the outcome of the patient. CP in severe TBI is to protect the brain from further insults, optimise cerebral metabolism and prevent secondary brain injury. This study aimed to analyse the short-term Glasgow Outcome Scale (GOS) at the intensive care unit (ICU) discharge and a month after ICU discharge of patients post CP and factors associated with the favourable outcome.

Methods: This is a prospective cohort study from January 2021 to January 2022. The short-term outcomes of patients were evaluated upon ICU discharge and 1 month after ICU discharge using GOS. Favourable outcome was defined as GOS 4 and 5. Generalised Estimation Equation (GEE) was adopted to conduct bivariate GEE and subsequently multivariate GEE to evaluate the factors associated with favourable outcome at ICU discharge and 1 month after discharge.

Results: A total of 92 patients with severe TBI with GOS of 8 and below admitted to ICU received CP management. Proportion of death is 17% at ICU discharge and 0% after 1 month of ICU discharge. Proportion of favourable outcome is 26.1% at ICU discharge and 61.1% after 1 month of ICU discharge. Among factors evaluated, age (odds ratio [OR] = 0.96; 95% CI: 0.94, 0.99; P = 0.004), duration of CP (OR = 0.41; 95% CI: 0.20, 0.84; P = 0.014) and hyperosmolar therapy (OR = 0.41; CI 95%: 0.21, 0.83; P = 0.013) had significant association.

Conclusion: CP in younger age, longer duration of CP and patient not receiving hyperosmolar therapy are associated with favourable outcomes. We recommend further clinical trial to assess long term outcome of CP.

严重创伤性脑损伤后患者脑保护治疗的短期疗效分析:单神经外科中心研究。
背景:严重创伤性脑损伤(TBI)是全球致残的主要原因之一,脑保护(CP)管理可能决定患者的结局。对严重创伤性脑损伤患者实施脑保护是为了保护大脑免受进一步的损伤,优化脑代谢,防止继发性脑损伤。本研究旨在分析CP后患者在重症监护室(ICU)出院时和出院一个月后的短期格拉斯哥结果量表(GOS)以及与良好结果相关的因素:这是一项前瞻性队列研究,研究时间为2021年1月至2022年1月。使用GOS评估患者在ICU出院时和出院后1个月的短期疗效。良好预后定义为 GOS 4 和 5。采用广义估计方程(GEE)进行二变量 GEE,然后进行多变量 GEE,以评估与 ICU 出院时和出院后 1 个月的良好预后相关的因素:共有 92 名 GOS 为 8 及以下的严重创伤性脑损伤患者入住重症监护室,接受了 CP 治疗。重症监护室出院时的死亡比例为 17%,出院 1 个月后的死亡比例为 0%。重症监护室出院时转危为安的比例为 26.1%,出院 1 个月后转危为安的比例为 61.1%。在评估的因素中,年龄(几率比 [OR] = 0.96;95% CI:0.94,0.99;P = 0.004)、CP 持续时间(OR = 0.41;95% CI:0.20,0.84;P = 0.014)和高渗治疗(OR = 0.41;CI 95%:0.21,0.83;P = 0.013)有显著关联:结论:CP 年龄越小、CP 持续时间越长、未接受高渗治疗的患者预后越好。我们建议进一步开展临床试验,以评估 CP 的长期预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Malaysian Journal of Medical Sciences
Malaysian Journal of Medical Sciences MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.70
自引率
0.00%
发文量
89
审稿时长
9 weeks
期刊介绍: The Malaysian Journal of Medical Sciences (MJMS) is a peer-reviewed, open-access, fully online journal that is published at least six times a year. The journal’s scope encompasses all aspects of medical sciences including biomedical, allied health, clinical and social sciences. We accept high quality papers from basic to translational research especially from low & middle income countries, as classified by the United Nations & World Bank (https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519), with the aim that published research will benefit back the bottom billion population from these countries. Manuscripts submitted from developed or high income countries to MJMS must contain data and information that will benefit the socio-health and bio-medical sciences of these low and middle income countries. The MJMS editorial board consists of internationally regarded clinicians and scientists from low and middle income countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信